FindTrial
Sign In

Using a blood test Adrenomedullin to predict disease severity and outcome in patients with fever presenting to Emergency Department

Utility of Adrenomedullin as a novel biomarker to predict disease severity and outcome in patients with Acute febrile illness presenting to Emergency Department: A prospective observational study. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/054779
Enrollment
147
Registered
2023-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A90- Dengue fever [classical dengue] Health Condition 2: A488- Other specified bacterial diseases Health Condition 3: A753- Typhus fever due to Rickettsia tsutsugamushi

Interventions

None listed

Sponsors

Manipal Centre for Infectious Diseases (MACID)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient presenting to Emergency Department with Acute febrile illness with no single localised source of infection 2. Within 24 hours of hospital admission at the time of enrollment.

Exclusion criteria

Exclusion criteria: 1. Not consenting to participate in the study 2. Intent of treatment is palliative

Design outcomes

Primary

MeasureTime frame
Survival/ Death of the patientTimepoint: Survival/Death will be assessed on day 28 since admission—

Secondary

MeasureTime frame
7-day mortality; need for ventilation (either invasive or non-invasive), development of shock, ventilator-free days and vasopressor free days at 28 days.Timepoint: 7 days, 28 days—

Countries

India

Contacts

Public ContactDr Prithvishree Ravindra

Kasturba Medical College, Manipal

prithvishree@gmail.com9035296971

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026